Yale Nobel Laureate Honored with Connecticut Medal of Science
News Apr 22, 2013
Best known for his research into ribosomal proteins, the building blocks of all life, Steitz is also renowned for his work with dozens of student mentees who became scientific leaders, themselves.
Steitz co-founded New Haven-based Rib-X Pharmaceuticals in 2001 to develop new classes of antibiotics. Today, the company has 45 full-time employees.
In addition to the 2009 Nobel Prize in Chemistry, Steitz has received a Gairdner International Award, a Keio Medical Science Prize, the AAAS Newcomb Cleveland Prize, and many other honors.
Measuring Neutrophil Motility Could Lead to Accurate Sepsis DiagnosisNews
Mass. General researchers design device that rapidly diagnoses sepsis with more than 95 percent accuracy.READ MORE
Malaria Prevention: New Antibody Targets Unique Binding SiteNews
Scientists have discovered a human antibody that, when tested in mice, prevented malaria infection by binding a specific portion of a surface protein found in almost all strains of the malaria parasite worldwide.READ MORE
Comments | 0 ADD COMMENT
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018